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NepalAbstract A 46-year-old female patient developed severe abdominal pain shortly after taking lev-
ofloxacin, 1000 mg for acute bacterial sinusitis. The pain started after taking the first dose of levo-
floxacin and became worse after the second dose. The patient was unable to do daily physical
activities. The pain resolved upon discontinuation of levofloxacin and symptomatic therapy. Other
factors that may cause abdominal pain were ruled out. This case is of interest as it documents severe
abdominal pain due to levofloxacin requiring discontinuation of therapy and describes its appropri-
ate management. In addition, it highlights the vital role that community pharmacists could play in
managing adverse drug reactions (ADRs) and preventing potential Drug Related Problems (DRPs).
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Fluoroquinolone classes are among the best selling drugs in Ne-
pal. Two fluoroquinolone antibiotics are among the 15 top sell-
ing drugs in Nepal (Kafle et al., 2007). Levofloxacin is a newer
antibiotic from the fluoroquinolone group and is used for the
treatment of community-acquired pneumonia, nosocomial
pneumonia, chronic bronchitis, acute bacterial sinusitis, uri-
nary tract infection, acute pyelonephritis, and skin or skinstructure infections (Lacy et al., 2010). Common adverse effects
of levofloxacin include headache, GI symptoms, insomnia,
nausea, diarrhoea and pharyngitis. Although abdominal pain
is a reported adverse reaction that may occur due to levofloxa-
cin, in this case a severe abdominal cramp developed during the
use of levofloxacin which severely affected patient’s physical
activity and resulted in discontinuation of therapy.
2. Case report
A 46-year-old female with abdominal pain since one day was
presented to the community pharmacist. After verifying the
location of the pain, severity was assessed using the McCaffery
scale (1–10 pain severity assessment scale). The community
pharmacist rated her pain to be 7 on a scale of 10 and found
that the pain worsened on ambulation (McCaffery and Pasero,
1999). Further assessment by the community pharmacist
revealed a severe pain in right upper and left upper quadrant
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cramp. Further history taking revealed that she was diagnosed
with acute bacterial sinusitis recently and was prescribed levo-
floxacin 1000 mg once daily. The patient was given hyoscine
butylbromide 10 mg twice daily PRN (when necessary) to pro-
vide symptomatic relief from her abdominal cramp. The phar-
macist counselled the patient and asked her to follow up with
in case the pain persists. The next day the patient returned to
the pharmacy. Her abdominal pain was worse and moreover,
she explained that it started after she took levofloxacin. Her
pain remained 7 on a scale of 10 and worsened on ambulation.
The community pharmacist suspected the abdominal cramp
was due to levofloxacin and performed a complete history tak-
ing. Medical history revealed that the patient was diagnosed
with hypothyroidism two years ago and was prescribed levo-
thyroxine 100 mcg once daily. As the thyroid level returned
normal, the dose was gradually tapered and the patient discon-
tinued levothyroxine supplement since past 6 months on her
physicians’ advice. The patient was also diagnosed with hyper-
tension three months ago and was on amlodipine 5 mg once
daily. The patient was obese and her body mass index (BMI)
was 30.6. Four days before, she experienced headache, running
nose and flu-like symptoms, and visited hospital nearby. The
physician carried out nasal rhinoscopy, blood culture and
physical examination of the forehead to check the bones,
and diagnosed her with acute bacterial sinusitis. She was pre-
scribed a 5 day course of levofloxacin 1000 mg once daily.
After the first day of the regimen, she experienced mild abdom-
inal pain which worsened on the second day of levofloxacin
regimen. The patient was unable to continue her daily physical
activities and came to the community pharmacy.
On examination, the patient had tender pain and com-
plained of moderate to severe pain in all four abdominal quad-
rants. She said that the pain increased on ambulation. The
pain increase on ambulation and was of the throbbing type
affecting her daily life physical activities. The patient reported
to experience pain in 2–3 h after taking her daily dose of levo-
floxacin. Physiologically, the patient was not in her menstrual
period. The pharmacist also performed thorough interview to
rule out gynaecological issue like menstrual cramp and adverse
effect of any oral contraceptive pills (OCP). She was not using
OCP such as levonorgesterol which might have an adverse
event such as abdominal cramp. The pharmacist asked her
to discontinue levofloxacin and to contact her physician imme-
diately. A referral note about her abdominal cramp and its
possible relation to levofloxacin dosing was made and attached
to her medical report. The physician performed physical exam-
ination and confirmed the abdominal cramps. The physician
also performed blood test (FBC) to avoid acute pancreatitis
and performed endoscopy to rule out peptic ulcer and gastritis.
Suspecting the abdominal cramp to be due to levofloxacin, the
physician stopped levofloxacin and changed it with co-trimox-
azole 960 mg twice daily for 7 days together with ranitidine
150 mg once daily. Her abdominal cramp was significantly im-
proved and the pain was relieved by the second day of discon-
tinuation of levofloxacin. A follow-up by the community
pharmacist indicated that, within approximately 1 week of
the treatment her sinusitis had improved, and she experienced
no sign of abdominal pain during the course of co-trimoxazole
treatment. She had no recurrence of pain, and was able to
resume walking normally and returns to work.3. Discussion
We present a case of severe abdominal cramp that developed
during the use of levofloxacin by a 46-year-old female. Use
of the Naranjo probability scale demonstrated a possible asso-
ciation between levofloxacin and this adverse effect (Naranjo
et al., 1981). Although factors that may cause abdominal pain
(e.g. irritable bowel syndrome) were ruled out, not all factors
that may cause abdominal cramp could be ruled out with cer-
tainty. Nevertheless, we believe levofloxacin was the most
likely agent, since the patient was pursuing a normal routine
lifestyle, she was not on her menstrual period, and she had
not experienced any physical strain or injury to her abdominal
region. We believe that the abdominal cramp may have been
caused by the high dose of levofloxacin.
The fluoroquinolone antibiotic class can cause the gastroin-
testinal tract problems such as nausea and diarrhoea, and ad-
verse central nervous system (CNS) effects such as headache
and dizziness. These adverse events are usually mild and do
not require discontinuation of therapy (Mandel and Tillotson,
2002). Although abdominal pain is also listed as an adverse ef-
fect of levofloxacin, abdominal cramp due to fluoroquinolone
requiring discontinuation of therapy is a rare adverse effect,
and makes this case worth sharing. In this patient, abdominal
cramp started 2–3 h after taking levofloxacin and was resolved
upon discontinuation of levofloxacin.
The fluoroquinolone antibiotic class is generally well toler-
ated (Mandel and Tillotson, 2002). The incidence of abdomi-
nal pain due to levofloxacin is estimated to be 2% (Lacy
et al., 2010). Levofloxacin-induced tendinopathy has been well
reported, and carriers are required by the United States Food
and Drug Administration to display a black box warning
describing possible tendinopathy (Ganske and Horning,
2012). To our knowledge, this case is unique, since the case in-
volved severe abdominal cramp believed to be caused by levo-
floxacin which required stopping levofloxacin and changing to
other medication. The exact cause of levofloxacin induced
abdominal pain is not known but levofloxacin might have
caused inflammation of the parietal peritoneum which caused
innervations of somatic nerve. The pain was exacerbated by
movement and developed as abdominal rigidity and guarding
(Nicki et al., 2010). While systematic studies are lacking, there
have been reports of levofloxacin induced abdominal pain by
patients in various forms, but most were not as severe as this
case. (Treato Pharma, 2012). Another study by eHealthMe
(2012) involving 5341 levofloxacin users showed that 155 peo-
ple (2.90%) reported abdominal pain while taking
levofloxacin.
The patient was taking amlodipine 5 mg once daily, and
amlodipine is not known to cause severe abdominal pain.
The patient was not having a menstrual period which could
cause abdominal cramp. Though the patient is obese (BMI
30.6), she was not involved in any strenuous physical activity
which could cause or worsen abdominal cramp. The dose of
levofloxacin for acute bacterial sinusitis is 500 mg once daily
for 10–14 days or 750 mg once daily for 5 days, while this pa-
tient received a dose of 1000 mg of levofloxacin once daily.
This is higher than the recommended daily dose, and may have
caused abdominal cramp, or had a role in worsening abdomi-
nal cramp. A multicenter randomized double-blind study con-
ducted in United States comparing the effect of levofloxacin
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daily for 5 days for acute bacterial sinusitis showed that levo-
floxacin 750 mg once daily for 5 days was not inferior to the
lower dose (Poole et al., 2006). Thus the high dose of levoflox-
acin was not justified. Though there is not clear evidence for
dose-related adverse events with levofloxacin, the higher dose
might have caused abdominal cramp or worsened the pain.
Treatment for abdominal pain associated with levofloxacin in-
volves discontinuation of therapy, using antispasmodic drugs
such as hyoscine butylbromide, proper rest, and avoidance
of strenuous physical activity. The symptoms disappear after
discontinuation of the drug. Use of subjective assessment tools
to determine patients’ abdominal pain and careful palpation
may be useful in detecting abdominal cramp (McCaffery and
Pasero, 1999). Consideration should be given to proper coun-
selling of the patient about the possible adverse effect of med-
icines. Though Nepal does not provide systematic clinical
practice guidelines for the treatment of specific medical condi-
tions, the physician should adhere to the antibiotic dosing rec-
ommendations of international professional societies
(Rosenfeld et al., 2007). Exceeding the daily recommended
dose of antibiotics may lead to an adverse drug reaction, or
worsen an existing reaction.
A community pharmacist can play a vital role in counsel-
ling the patient during the time of therapy, and provide proper
guidance and referral of the patient to a higher care centre
after an adverse drug reaction. Furthermore, for a resource-
scarce country like Nepal, the community pharmacist can play
a great role by promoting the safe use of medicine within the
community. Since pharmacists work in close contact with pa-
tients and are often the first point of referral for patients at the
community level, a community pharmacy run by a pharmacist
can act as a bridge between the physician and the patient. A
pharmacist can assist the patient with the prescription, and
may also intervene at the appropriate time in the case of an ad-
verse drug reaction, such as this case.4. Conclusion
There is a possible association between the adverse effect
(severe abdominal pain) and levofloxacin. The severe pain re-
quired immediate intervention and discontinuation of therapy.
Thus, community pharmacists, as essential part of primary
healthcare system, should play more active roles and counsel
and educate patients about the possibility and incidence of
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